Drug Approval | March 13, 2023
Shilpa Medicare gets 2 minor observations from USFDA for Unit VII, Analytical Services Division
The company will be submitting the responses to US FDA observations within stipulated timeline
The company will be submitting the responses to US FDA observations within stipulated timeline
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
Time to combine innovation, access and technology to deliver positive patient outcomes
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
The business serves the healthcare and laboratory sectors on the west coast of the United States.
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
Thiamine Hydrochloride Injection is effective in the treatment of vitamin B1 deficiency (beriberi)
Subscribe To Our Newsletter & Stay Updated
